Press Release

Healthcare Trust of America, Inc. Reports Third Quarter 2018 Earnings

Normalized FFO of $0.41 Per Diluted Share

Same-Property Cash NOI Growth of 2.5%

Completed $306 Million of Dispositions in Non-Core Properties

Company Release - 10/25/2018 4:05 PM ET

SCOTTSDALE, Ariz., Oct. 25, 2018 /PRNewswire/ -- Healthcare Trust of America, Inc. (NYSE: HTA) ("HTA") announced results for the three and nine months ended September 30, 2018.

Healthcare Trust of America, Inc. Logo. (PRNewsFoto/Healthcare Trust of America, Inc.) (PRNewsfoto/Healthcare Trust of America, In)

Operating

Third Quarter 2018:

  • Net Income Attributable to Common Stockholders: Increased $159.2 million, to $173.0 million, compared to Q3 2017. Earnings per diluted share increased $0.75, to $0.82 per diluted share, compared to Q3 2017.
  • Funds From Operations ("FFO"): As defined by the National Association of Real Estate Investment Trusts ("NAREIT"), decreased (3.4)%, to $81.4 million, compared to Q3 2017. FFO per diluted share decreased (7.3)%, to $0.38 per diluted share, compared to Q3 2017.
  • Normalized FFO: Increased 0.8%, to $86.1 million, compared to Q3 2017. Normalized FFO per diluted share decreased (2.4)%, to $0.41 per diluted share, compared to Q3 2017.
  • Normalized Funds Available for Distribution ("FAD"): Decreased (8.0)%, to $68.8 million, compared to Q3 2017.
  • Same-Property Cash Net Operating Income ("NOI"): Increased $2.7 million, or 2.5%, to $108.8 million, compared to Q3 2017.

Year-to-Date 2018:

  • Net Income Attributable to Common Stockholders: Increased $176.7 million, to $198.1 million, compared to 2017. Earnings per diluted share increased $0.82, to $0.94 per diluted share, compared to 2017.
  • FFO: As defined by NAREIT, increased 26.0%, to $250.4 million, compared to 2017. FFO per diluted share increased 6.3%, to $1.19 per diluted share, compared to 2017.
  • Normalized FFO: Increased 19.0%, to $256.2 million, compared to 2017. Normalized FFO per diluted share increased 0.8%, to $1.22 per diluted share, compared to 2017.
  • Normalized FAD: Increased 15.3%, to $217.0 million, compared to 2017.
  • Same-Property Cash NOI: Increased $5.6 million, or 2.4%, to $233.2 million, compared to 2017. Excluding the MOBs located on its Forest Park Dallas campus, Same-Property Cash NOI growth was 2.7%.

Portfolio

  • Leasing: During the three months ended September 30, 2018, HTA entered into new and renewal leases on approximately 532,000 square feet of gross leasable area ("GLA"), or 2.3%, of its portfolio. Tenant retention for the Same-Property portfolio was 82% by GLA for the quarter, which included approximately 381,000 square feet of GLA of total expiring leases. Re-leasing spreads for renewal leases on a cash basis were approximately 3.7%. Renewal leases included tenant improvements of $1.53 per square foot of GLA per year of the lease term and less than one day of free rent per year of the lease term during the three months ended September 30, 2018.
  • Leased Rate: As of September 30, 2018, HTA had a leased rate for its portfolio of 92.1% by GLA and an occupancy rate of 90.9% by GLA.
  • Forest Park Update: During the three months ended September 30, 2018, HTA entered into approximately 41,000 square feet of GLA of new leases on the former Forest Park Dallas campus (the "Campus"), bringing total new leasing for the Campus to 81,000 square feet of GLA for the nine months ended September 30, 2018. The total leased rate for the Campus was approximately 84% as of September 30, 2018.
  • Dispositions: During the three months ended September 30, 2018, HTA completed the disposition of 19 MOBs, primarily located in Greenville, South Carolina for an aggregate gross sales price of $305.9 million and totaling approximately 1.1 million square feet of GLA, generating gains of approximately $166.4 million, and consisted of the following:
    • In August 2018, HTA completed the disposition of its Greenville, South Carolina MOB portfolio (the "Greenville Disposition"), which consisted of 17 MOBs for an aggregate gross sales price of $294.3 million in two transactions, including (i) the sale of a single MOB which HTA classified as held for sale as of June 30, 2018, and (ii) the Greenville Disposition which consisted of approximately 965,000 square feet of GLA.
    • Additionally, HTA completed the disposition of two MOBs located in Derry, New Hampshire and North Adams, Massachusetts for an aggregate gross sales price of $11.6 million, totaling approximately 120,000 square feet of GLA.
  • Development/Redevelopment: During the nine months ended September 30, 2018, HTA announced a new development in its key gateway market of Miami, Florida and commenced two redevelopments, including an agreement to build a new on-campus MOB in Raleigh, North Carolina. These projects will have total expected construction costs of approximately $70.6 million and are approximately 78% pre-leased to major health systems.
  • Investments: During the nine months ended September 30, 2018, HTA invested approximately $13.9 million to acquire three MOBs of approximately 60,000 square feet of GLA in the key market of Raleigh, North Carolina. In addition, HTA invested approximately $3.9 million to consolidate its ownership interests in several other MOBs.

2017 Investment Performance

  • Cash NOI: During the three months ended September 30, 2018, HTA generated $36.4 million of Cash NOI from its 2017 investments, including its investment in its unconsolidated joint venture. As of September 30, 2018, HTA's run rate yield on its 2017 investments was approximately 5.3%, which included the full year impact of new leases which have been executed, but which have not yet commenced.
  • Development: As part of the 2017 investments, HTA acquired seven development projects that were under construction and not stabilized at the date of acquisition. During the quarter, HTA completed the remaining development of the Providence Facey MOB in Los Angeles, California. This MOB is approximately 37,000 square feet of GLA and is 100% pre-leased.

Balance Sheet and Capital Markets

  • Balance Sheet: As of September 30, 2018, HTA had total leverage of 29.7%, measured as debt less cash and cash equivalents to total capitalization, and 5.3x, measured as debt less cash and cash equivalents to Adjusted Earnings before Interest, Taxes, Depreciation and Amortization for real estate ("Adjusted EBITDAre"). Total liquidity at the end of the quarter was $1.2 billion, including $994.5 million of availability under HTA's unsecured revolving credit facility and $225.5 million of cash and cash equivalents.
  • Debt: In August 2018, HTA prepaid approximately $72.6 million of its fixed and variable rate mortgages, including the settlement of three cash flow hedges, utilizing net proceeds from the Greenville Disposition to do so. Additionally, in August 2018, HTA's operating partnership, HTALP, entered into a modification of its $200.0 million unsecured term loan previously due in 2023. This modification decreased pricing at HTA's current credit rating by 65 bps. The maturity date was also extended by five months to January 2024. The other material terms of the unsecured term loan prior to the modification remained substantially unchanged.
  • Stock Repurchase Plan: In August 2018, HTA's Board of Directors approved a stock repurchase plan authorizing HTA to purchase up to $300.0 million of its common stock from time to time. During the nine months ended September 30, 2018, HTA repurchased 628,002 shares of its common stock at an average price of $26.25 per share, for an aggregate amount of approximately $16.5 million. As of September 30, 2018, the remaining amount of common stock available for repurchase under the stock repurchase plan was approximately $283.5 million.

Impact of Future Accounting Standards

  • Topic 842 Leases: In February 2016, the Financial Accounting Standards Board issued Topic 842, which is effective for HTA as of January 1, 2019. As part of Topic 842, companies are required to expense initial direct costs that are currently capitalized. For the nine months ended September 30, 2018, HTA capitalized approximately $3.7 million of internal costs related to leasing activities. Utilizing a traditional third party leasing commission structure of 3% of gross lease value, total leasing commissions would have totaled over $9 million during the nine months ended September 30, 2018.

    As of January 1, 2019, these external costs, which are primarily external broker fees and external legal fees, will be recorded in HTA's consolidated statement of operations as additional general and administrative expenses.  HTA estimates the range of these expenses to be approximately $6 million to $8 million on an annualized basis and effecting Earnings Per Share and corresponding FFO by approximately $0.03 to $0.04 per share on an annualized basis.

Subsequent Events

  • Debt: Subsequent to September 30, 2018, HTA prepaid approximately $67.2 million of its fixed rate mortgages. HTA did not incur any prepayment fees related to this transaction.
  • Dividends: On October 25, 2018, HTA's Board of Directors announced a quarterly dividend of $0.310 per share of common stock and per OP Unit. The quarterly dividend is to be paid on January 9, 2019 to stockholders of record of its common stock and holders of its OP Units on January 2, 2019.
  • Stock Repurchase Plan: Subsequent to September 30, 2018, HTA repurchased 289,519 shares of its common stock at an average price of $25.69 per share, for an aggregate amount of approximately $7.4 million under its stock repurchase plan.

Financial Results - Third Quarter 2018

Rental Income

Rental income decreased (0.2)% to $175.0 million for the three months ended September 30, 2018, compared to $175.4 million for the three months ended September 30, 2017.

Net Income

Net income increased $162.4 million, to $176.3 million for the three months ended September 30, 2018, compared to $14.0 million for the three months ended September 30, 2017.

FFO

FFO, as defined by NAREIT, was $0.38 per diluted share, or $81.4 million, for the three months ended September 30, 2018, compared to $0.41 per diluted share, or $84.2 million, for the three months ended September 30, 2017.

Normalized FFO

Normalized FFO was $0.41 per diluted share, or $86.1 million, for the three months ended September 30, 2018, compared to $0.42 per diluted share, or $85.4 million, for the three months ended September 30, 2017.

Normalized FAD

Normalized FAD decreased (8.0)% to $68.8 million, for the three months ended September 30, 2018, compared to $74.8 million for the three months ended September 30, 2017.

NOI

NOI decreased (0.3)% to $119.3 million for the three months ended September 30, 2018, compared to $119.7 million for the three months ended September 30, 2017.

Same-Property Cash NOI

Same-Property Cash NOI increased $2.7 million, or 2.5%, to $108.8 million, for the three months ended September 30, 2018, compared to $106.2 million for the three months ended September 30, 2017.

General and Administrative Expenses

General and administrative expenses were $8.8 million for the three months ended September 30, 2018, compared to $8.3 million for the three months ended September 30, 2017.

Interest Expense

Total interest expense was $24.8 million for the three months ended September 30, 2018, compared to $26.2 million for the three months ended September 30, 2017.

Disposition Activity

During the three months ended September 30, 2018, HTA completed the disposition of 19 MOBs, primarily located in Greenville, South Carolina for an aggregate gross sales price of $305.9 million and totaling approximately 1.1 million square feet of GLA, generating gains of approximately $166.4 million.

Tenant Retention

Tenant retention for the Same-Property portfolio was 82% by GLA for the quarter, which included approximately 381,000 square feet of GLA of expiring leases.

Financial Results - Year-to-Date 2018

Rental Income

Rental income increased 19.3% to $523.8 million for the nine months ended September 30, 2018, compared to $438.9 million for the nine months ended September 30, 2017.

Net Income

Net income increased $179.9 million to $202.0 million for the nine months ended September 30, 2018, compared to $22.1 million for the nine months ended September 30, 2017.

FFO

FFO, as defined by NAREIT, was $1.19 per diluted share, or $250.4 million, for the nine months ended September 30, 2018, compared to $1.12 per diluted share, or $198.7 million, for the nine months ended September 30, 2017.

Normalized FFO

Normalized FFO was $1.22 per diluted share, or $256.2 million, for the nine months ended September 30, 2018, compared to $1.21 per diluted share, or $215.2 million, for the nine months ended September 30, 2017.

Normalized FAD

Normalized FAD increased 15.3% to $217.0 million, for the nine months ended September 30, 2018, compared to $188.3 million for the nine months ended September 30, 2017.

NOI

NOI increased 19.1% to $358.8 million for the nine months ended September 30, 2018, compared to $301.3 million for the nine months ended September 30, 2017.

Same-Property Cash NOI

Same-Property Cash NOI increased $5.6 million, or 2.4%, to $233.2 million, for the nine months ended September 30, 2018, compared to $227.6 million for the nine months ended September 30, 2017.  Excluding the MOBs located on HTA's Forest Park Dallas campus, Same-Property Cash NOI growth was 2.7%.

General and Administrative Expenses

General and administrative expenses were $26.3 million for the nine months ended September 30, 2018, compared to $25.2 million for the nine months ended September 30, 2017.

Interest Expense

Total interest expense was $77.4 million for the nine months ended September 30, 2018, compared to $59.6 million for the nine months ended September 30, 2017.

Investment Activity

During the nine months ended September 30, 2018, HTA invested $13.9 million to acquire three MOBs of approximately 60,000 square feet of GLA in the key market of Raleigh, North Carolina.  In addition, HTA invested $3.9 million to consolidate its ownership interests in several other MOBs.

Leased Rate, Occupancy Rate and Tenant Retention

The leased rate (which includes leases which have been executed, but which have not yet commenced) was 92.1% by GLA as of September 30, 2018.  The occupancy rate of HTA's portfolio was 90.9% by GLA as of September 30, 2018.  Tenant retention for the Same-Property portfolio was 83% by GLA year-to-date, which included approximately 1.7 million square feet of GLA of expiring leases.

Credit Rated Tenants

Investment grade rated tenants as a percent of annualized base rent was 46% as of September 30, 2018.  Additionally, 59% of HTA's annualized base rent as of September 30, 2018 was derived from tenants that have (or whose parent companies have) a credit rating from a nationally recognized rating agency.

In-House Property Management and Leasing Platform

As of September 30, 2018, HTA's in-house property management and leasing platform operated approximately 21.7 million square feet of GLA, or 93%, of its total portfolio.

About Healthcare Trust of America, Inc.

Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of MOBs in the United States, comprising approximately 23.2 million square feet of GLA, with $6.8 billion invested primarily in MOBs.  HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations.  Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth.  The strategic markets HTA invests in support a strong, long-term demand for quality medical office space.  HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market.  This drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation.  Headquartered in Scottsdale, Arizona, HTA has developed a national brand with dedicated relationships at the local level.

Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the S&P 500 and US REIT indices.  More information about HTA can be found on the Company's Website (www.htareit.com), Facebook, LinkedIn and Twitter.

Forward-Looking Language

This press release contains certain forward-looking statements with respect to HTA.  Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management's intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements.  These risks, uncertainties and contingencies include, without limitation, the following: changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in our proposed market areas; changes in accounting principles generally accepted in the United States of America; policies and guidelines applicable to REITs; the availability of properties to acquire; and the availability of financing.  Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our 2017 Annual Report on Form 10-K and in our filings with the SEC.

Conference Call

HTA will host a conference call and webcast on Friday, October 26, 2018 at 12:00 p.m. Eastern Time (9:00 a.m. Pacific Time) to review its financial performance and operating results for the three and nine months ended September 30, 2018.

Conference Call and Webcast Details:
Domestic Dial-In Number: (877) 507-6265
International Dial-In Number: (412) 902-6633
Canada Dial-In Number: (855) 669-9657
Webcast: www.htareit.com under the Investor Relations tab

Replay Conference Call Details:
Domestic Dial-In Number: (877) 344-7529
International Dial-In Number: (412) 317-0088
Canada Dial-In Number: (855) 669-9658
Conference ID: 10125150
Available October 26, 2018 (one hour after the end of the conference call) to November 26, 2018 at 12:00 p.m. Eastern Time (9:00 a.m. Pacific Time)

Financial Contact:
Robert A. Milligan
Chief Financial Officer
480.998.3478

HEALTHCARE TRUST OF AMERICA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except for share and per share data)

(Unaudited)



September 30, 2018


December 31, 2017

ASSETS




Real estate investments:




Land

$

483,541



$

485,319


Building and improvements

5,743,439



5,830,824


Lease intangibles

604,215



639,199


Construction in progress

27,273



14,223



6,858,468



6,969,565


Accumulated depreciation and amortization

(1,151,490)



(1,021,691)


Real estate investments, net

5,706,978



5,947,874


Investment in unconsolidated joint venture

67,592



68,577


Cash and cash equivalents

225,518



100,356


Restricted cash

14,639



18,204


Receivables and other assets, net

213,482



207,857


Other intangibles, net

100,475



106,714


Total assets

$

6,328,684



$

6,449,582


LIABILITIES AND EQUITY




Liabilities:




Debt

$

2,609,659



$

2,781,031


Accounts payable and accrued liabilities

160,246



167,852


Derivative financial instruments - interest rate swaps



1,089


Security deposits, prepaid rent and other liabilities

55,753



61,222


Intangible liabilities, net

62,887



68,203


Total liabilities

2,888,545



3,079,397


Commitments and contingencies




Redeemable noncontrolling interests

6,610



6,737


Equity:




Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding




Class A common stock, $0.01 par value; 1,000,000,000 shares authorized; 207,231,171 and 204,892,118 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively

2,072



2,049


Additional paid-in capital

4,574,913



4,508,528


Accumulated other comprehensive income

648



274


Cumulative dividends in excess of earnings

(1,224,006)



(1,232,069)


Total stockholders' equity

3,353,627



3,278,782


Noncontrolling interests

79,902



84,666


Total equity

3,433,529



3,363,448


Total liabilities and equity

$

6,328,684



$

6,449,582


 

HEALTHCARE TRUST OF AMERICA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)



Three Months Ended September 30,


Nine Months Ended September 30,


2018


2017


2018


2017

Revenues:








Rental income

$

175,038



$

175,431



$

523,826



$

438,949


Interest and other operating income

97



563



302



1,271


Total revenues

175,135



175,994



524,128



440,220


Expenses:








Rental

55,789



56,331



165,364



138,874


General and administrative

8,770



8,283



26,281



25,178


Transaction

346



261



933



5,618


Depreciation and amortization

70,568



70,491



210,064



172,900


Impairment

4,281





8,887



5,093


Total expenses

139,754



135,366



411,529



347,663


Income before other income (expense)

35,381



40,628



112,599



92,557


Interest income (expense):








Interest related to derivative financial instruments

169



(264)



297



(827)


Gain on change in fair value of derivative financial instruments, net







884


Total interest related to derivative financial instruments, including net change in fair value of derivative financial instruments

169



(264)



297



57


Interest related to debt

(25,003)



(25,924)



(77,689)



(59,688)


Gain on sale of real estate, net

166,372





166,372



3


Loss on extinguishment of debt, net

(1,092)



(774)



(1,092)



(11,192)


Income from unconsolidated joint venture

432



318



1,405



381


Other income (expense)

89



(27)



129



(13)


Net income

$

176,348



$

13,957



$

202,021



$

22,105


Net income attributable to noncontrolling interests

(3,362)



(194)



(3,887)



(715)


Net income attributable to common stockholders

$

172,986



$

13,763



$

198,134



$

21,390


Earnings per common share - basic:








Net income attributable to common stockholders

$

0.83



$

0.07



$

0.96



$

0.12


Earnings per common share - diluted:








Net income attributable to common stockholders

$

0.82



$

0.07



$

0.94



$

0.12


Weighted average common shares outstanding:








Basic

207,513



200,674



205,950



173,189


Diluted

211,444



204,795



209,968



177,410


Dividends declared per common share

$

0.310



$

0.305



$

0.920



$

0.905


 

HEALTHCARE TRUST OF AMERICA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)



Nine Months Ended September 30,


2018


2017

Cash flows from operating activities:




Net income

$

202,021



$

22,105


Adjustments to reconcile net income to net cash provided by operating activities:




Depreciation, amortization and other

203,550



169,057


Share-based compensation expense

7,830



5,493


Impairment

8,887



5,093


Income from unconsolidated joint venture

(1,405)



(381)


Distributions from unconsolidated joint venture

1,680




Gain on sale of real estate, net

(166,372)



(3)


Loss on extinguishment of debt, net

1,092



11,192


Change in fair value of derivative financial instruments



(884)


Changes in operating assets and liabilities:




Receivables and other assets, net

(7,820)



(19,854)


Accounts payable and accrued liabilities

(5,932)



29,566


Prepaid rent and other liabilities

(2,780)



7,158


Net cash provided by operating activities

240,751



228,542


Cash flows from investing activities:




Investments in real estate

(17,389)



(2,357,570)


Investment in unconsolidated joint venture



(68,839)


Development of real estate

(29,593)



(19,163)


Proceeds from the sale of real estate

302,440



4,746


Capital expenditures

(61,136)



(42,990)


Collection of real estate notes receivable

524




Net cash provided by (used in) investing activities

194,846



(2,483,816)


Cash flows from financing activities:




Borrowings on unsecured revolving credit facility

145,000



515,000


Payments on unsecured revolving credit facility

(145,000)



(528,000)


Proceeds from unsecured senior notes



900,000


Payments on secured mortgage loans

(173,212)



(75,444)


Deferred financing costs

(782)



(16,902)


Debt extinguishment costs

(1,909)



(10,391)


Security deposits

499



1,932


Proceeds from issuance of common stock

72,814



1,624,222


Issuance of operating partnership units

411




Repurchase and cancellation of common stock

(19,431)



(3,413)


Dividends paid

(188,414)



(145,877)


Distributions paid to noncontrolling interest of limited partners

(3,976)



(4,019)


Net cash (used in) provided by financing activities

(314,000)



2,257,108


Net change in cash, cash equivalents and restricted cash

121,597



1,834


Cash, cash equivalents and restricted cash - beginning of period

118,560



25,045


Cash, cash equivalents and restricted cash - end of period

$

240,157



$

26,879


 

HEALTHCARE TRUST OF AMERICA, INC.

NOI, CASH NOI AND SAME-PROPERTY CASH NOI

(In thousands)

(Unaudited)



Three Months Ended September 30,


Nine Months Ended September 30,


2018


2017


2018


2017

Net income

$

176,348



$

13,957



$

202,021



$

22,105


General and administrative expenses

8,770



8,283



26,281



25,178


Transaction expenses (1)

346



261



933



5,618


Depreciation and amortization expense

70,568



70,491



210,064



172,900


Impairment

4,281





8,887



5,093


Interest expense and net change in fair value of derivative financial instruments

24,834



26,188



77,392



59,631


Gain on sale of real estate, net

(166,372)





(166,372)



(3)


Loss on extinguishment of debt, net

1,092



774



1,092



11,192


Income from unconsolidated joint venture

(432)



(318)



(1,405)



(381)


Other (income) expense

(89)



27



(129)



13


NOI

$

119,346



$

119,663



$

358,764



$

301,346


NOI percentage growth

(0.3)%





19.1

%











NOI

$

119,346



$

119,663



$

358,764



$

301,346


Straight-line rent adjustments, net

(2,746)



(3,009)



(8,289)



(5,834)


Amortization of (below) and above market leases/leasehold interests, net

(65)



214



190



246


Notes receivable interest income and other GAAP adjustments

(33)



(588)



(218)



(1,163)


Cash NOI

$

116,502



$

116,280



$

350,447



$

294,595


Acquisitions not owned/operated for all periods presented and disposed properties Cash NOI

(6,065)



(7,337)



(112,557)



(59,865)


Redevelopment Cash NOI

(607)



(1,540)



(1,923)



(4,072)


Intended for sale Cash NOI

(1,007)



(1,243)



(2,815)



(3,063)


Same-Property Cash NOI (2)

$

108,823



$

106,160



$

233,152



$

227,595


Same-Property Cash NOI percentage growth

2.5

%




2.4

%





(1)

For the nine months ended September 30, 2017, transaction costs included $4.6 million of non-incremental costs related to the Duke acquisition.

(2)

Same-Property includes 403 and 317 buildings for the three and nine months ended September 30, 2018 and 2017, respectively.

NOI is a non-GAAP financial measure that is defined as net income or loss (computed in accordance with GAAP) before: (i) general and administrative expenses; (ii) transaction expenses; (iii) depreciation and amortization expense; (iv) impairment; (v) interest expense and net change in fair value of derivative financial instruments; (vi) gain or loss on sales of real estate; (vii) gain or loss on extinguishment of debt; (viii) income or loss from unconsolidated joint venture; and (ix) other income or expense.  HTA believes that NOI provides an accurate measure of the operating performance of its operating assets because NOI excludes certain items that are not associated with the management of its properties.  Additionally, HTA believes that NOI is a widely accepted measure of comparative operating performance of real estate investment trusts ("REITs").  However, HTA's use of the term NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount.  NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of its financial performance.  NOI should be reviewed in connection with other GAAP measurements.

Cash NOI is a non-GAAP financial measure which excludes from NOI: (i) straight-line rent adjustments; (ii) amortization of below and above market leases/leasehold interests; (iii) notes receivable interest income; and (iv) other GAAP adjustments.  Contractual base rent, contractual rent increases, contractual rent concessions and changes in occupancy or lease rates upon commencement and expiration of leases are a primary driver of HTA's revenue performance.  HTA believes that Cash NOI, which removes the impact of straight-line rent adjustments, provides another measurement of the operating performance of its operating assets.  Additionally, HTA believes that Cash NOI is a widely accepted measure of comparative operating performance of REITs.  However, HTA's use of the term Cash NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount.  Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of its financial performance.  Cash NOI should be reviewed in connection with other GAAP measurements.

To facilitate the comparison of Cash NOI between periods, HTA calculates comparable amounts for a subset of its owned and operational properties referred to as "Same-Property".  Same-Property Cash NOI excludes (i) properties which have not been owned and operated by HTA during the entire span of all periods presented and disposed properties, (ii) HTA's share of unconsolidated joint ventures, (iii) development, redevelopment and land parcels, (iv) properties intended for disposition in the near term which have (a) been approved by the Board of Directors, (b) is actively marketed for sale, and (c) an offer has been received at prices HTA would transact and the sales process is ongoing, and (v) certain non-routine items.  Same-Property Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of its financial performance.  Same-Property Cash NOI should be reviewed in connection with other GAAP measurements.

HEALTHCARE TRUST OF AMERICA, INC.

FFO, NORMALIZED FFO AND NORMALIZED FAD

(In thousands, except per share data)

(Unaudited)



Three Months Ended September 30,


Nine Months Ended September 30,


2018


2017


2018


2017

Net income attributable to common stockholders

$

172,986



$

13,763



$

198,134



$

21,390


Depreciation and amortization expense related to investments in real estate

70,004



70,021



208,445



171,678


Gain on sale of real estate, net

(166,372)





(166,372)



(3)


Impairment

4,281





8,887



5,093


Proportionate share of joint venture depreciation and amortization

463



464



1,277



506


FFO attributable to common stockholders

$

81,362



$

84,248



$

250,371



$

198,664


Transaction expenses

346



261



789



975


Gain on change in fair value of derivative financial instruments, net







(884)


Loss on extinguishment of debt, net

1,092



774



1,092



11,192


Noncontrolling income from partnership units included in diluted shares

3,344



166



3,822



635


Other normalizing items, net (1)





144



4,643


Normalized FFO attributable to common stockholders

$

86,144



$

85,449



$

256,218



$

215,225


Other (income) expense

(89)



27



(129)



13


Non-cash compensation expense

2,127



1,654



7,830



5,493


Straight-line rent adjustments, net

(2,746)



(3,009)



(8,289)



(5,834)


Amortization of (below) and above market leases/leasehold interests and corporate assets, net

499



683



1,809



1,467


Deferred revenue - tenant improvement related

(1)



(12)



(70)



(23)


Amortization of deferred financing costs and debt discount/premium, net

1,277



1,290



3,857



2,929


Recurring capital expenditures, tenant improvements and leasing commissions

(18,397)



(11,315)



(44,258)



(31,020)


Normalized FAD attributable to common stockholders

$

68,814



$

74,767



$

216,968



$

188,250










Net income attributable to common stockholders per diluted share

$

0.82



$

0.07



$

0.94



$

0.12


FFO adjustments per diluted share, net

(0.44)



0.34



0.25



1.00


FFO attributable to common stockholders per diluted share

$

0.38



$

0.41



$

1.19



$

1.12


Normalized FFO adjustments per diluted share, net

0.03



0.01



0.03



0.09


Normalized FFO attributable to common stockholders per diluted share

$

0.41



$

0.42



$

1.22



$

1.21










Weighted average diluted common shares outstanding

211,444



204,795



209,968



177,410




(1)

For the nine months ended September 30, 2017, other normalizing items included $4.6 million of non-incremental costs related to the Duke acquisition that were included in transaction expenses on HTA's condensed consolidated statements of operations.

HTA computes FFO in accordance with the current standards established by NAREIT.  NAREIT defines FFO as net income or loss attributable to common stockholders (computed in accordance with GAAP), excluding gains or losses from sales of real estate property and impairment write-downs of depreciable assets, plus depreciation and amortization related to investments in real estate, and after adjustments for unconsolidated partnerships and joint ventures.  HTA presents this non-GAAP financial measure because it considers it an important supplemental measure of its operating performance and believes it is frequently used by securities analysts, investors and other interested parties in the evaluation of REITs.  Historical cost accounting assumes that the value of real estate assets diminishes ratably over time.  Since real estate values have historically risen or fallen based on market conditions, many industry investors have considered the presentation of operating results for real estate companies that use historical cost accounting to be insufficient by themselves.  Because FFO excludes depreciation and amortization unique to real estate, among other items, it provides a perspective not immediately apparent from net income or loss attributable to common stockholders.

HTA computes Normalized FFO, which excludes from FFO: (i) transaction expenses; (ii) gain or loss on change in fair value of derivative financial instruments; (iii) gain or loss on extinguishment of debt; (iv) noncontrolling income or loss from partnership units included in diluted shares; and (v) other normalizing items, which include items that are unusual and infrequent in nature.  HTA presents this non-GAAP financial measure because it allows for the comparison of its operating performance to other REITs and between periods on a consistent basis.  HTA's methodology for calculating Normalized FFO may be different from the methods utilized by other REITs and, accordingly, may not be comparable to other REITs.  Normalized FFO should not be considered as an alternative to net income or loss attributable to common stockholders (computed in accordance with GAAP) as an indicator of its financial performance, nor is it indicative of cash available to fund cash needs.  Normalized FFO should be reviewed in connection with other GAAP measurements.

HTA also computes Normalized FAD, which excludes from Normalized FFO: (i) other income or expense; (ii) non-cash compensation expense; (iii) straight-line rent adjustments; (iv) amortization of below and above market leases/leasehold interests and corporate assets; (v) amortization of deferred financing costs and debt premium/discount; and (vi) recurring capital expenditures, tenant improvements and leasing commissions.  HTA believes this non-GAAP financial measure provides a meaningful supplemental measure of its operating performance.  Normalized FAD should not be considered as an alternative to net income or loss attributable to common stockholders (computed in accordance with GAAP) as an indicator of its financial performance, nor is it indicative of cash available to fund cash needs.  Normalized FAD should be reviewed in connection with other GAAP measurements.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/healthcare-trust-of-america-inc-reports-third-quarter-2018-earnings-300738015.html

SOURCE Healthcare Trust of America, Inc.

Investor Search